KRNY Form 4: Swansson granted 10,584 RSUs and holds 75,000 options
Rhea-AI Filing Summary
Timothy A. Swansson, EVP and CTIO of Kearny Financial Corp. (KRNY), filed a Form 4 reporting transactions dated 08/07/2025. The filing shows a reported purchase of 1,610 shares at $5.86 and a grant of 10,584 restricted stock units (RSUs).
The RSUs are described as vesting at 33% per year commencing August 7, 2026, and the filing also references RSU tranches with 33% annual vesting commencing in 2023–2025. Swansson is shown to directly hold 75,000 stock options with a $15.35 exercise price exercisable since 12/01/2017 and expiring 12/01/2026. The form was signed under power of attorney on 08/08/2025.
Positive
- Reported purchase of 1,610 shares at $5.86 (transaction dated 08/07/2025).
- Grant of 10,584 restricted stock units (RSUs) disclosed, with vesting at 33% per year beginning Aug 7, 2026.
- Confirmed ownership of 75,000 stock options with a $15.35 exercise price and expiration of 12/01/2026.
Negative
- None.
Insights
TL;DR: Form 4 reports routine executive compensation grants plus a small open-market purchase; limited immediate market impact.
The filing documents a 1,610-share purchase at $5.86 and a grant of 10,584 RSUs with a specified vesting schedule. These RSUs vest at 33% per year starting August 7, 2026, indicating multi-year compensation alignment. The report also confirms direct ownership of 75,000 stock options exercisable through December 1, 2026. Taken together, the disclosures are consistent with normal executive compensation and option holdings rather than a material change in corporate control or capital structure.
TL;DR: Disclosure shows standard compensation mechanics and clear vesting timelines; no governance red flags in this filing.
The Form 4 clearly itemizes restricted stock units and option holdings and specifies vesting commencement dates for multiple RSU tranches (2023–2026). The presence of RSUs that vest over several years suggests retention-focused design. The form was executed under power of attorney, and signature details are provided. There is no explicit indication in this filing of unusual related-party transactions or immediate dilution beyond ordinary compensation reporting.